Australia could draw some inspiration from other countries’ entertaining public awareness campaigns to counter vaccine hesitancy Australia’s vaccine rollout hasn’t exactly gone smoothly, or at least that’s what two-thirds of Australians think . There is concern about the pace of the rollout, as well as the potential side effects, especially after an advisory warned the AstraZeneca vaccine may cause extremely rare but potentially deadly blood clots for people under 50 . According to an ANU study, the most common reasons Australians were hesitant about the vaccine was concern about possible side-effects (63.3%), followed by those planning to “wait and see” (55%). Continue reading…
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots↳ 19:56, Benzinga • Développer
European Medical Agency (EMA) is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca Plc’s (NASDAQ: AZN ) COVID-19 vaccine, raising new questions about potential side effects of the shot. What Happened: As part of a regular review of safety reports for the vaccine, the safety committee of EMA is analyzing data provided by AstraZeneca on cases of Guillain-Barre syndrome (GBS). However, it did not specify the number of cases. The regulator said GBS was identified as a possible adverse event that needed to be specifically monitored during the vaccine’s conditional approval process, adding it had requested more detailed data on the cases from AstraZeneca. However, researchers have … Full story available on Benzinga.com
U.K. recommends those under 40 get an alternative to AstraZeneca’s vaccine, and other news from around the world.↳ 17:14, New York Times • Développer
No summary available.
As California moves toward reopening, another crisis is unfolding halfway across the globe. India recorded about 410,000 coronavirus cases Thursday, a new global high, and 3,980 deaths, the highest national daily death toll in any country outside the United States. Experts believe the true number of cases and deaths is much higher.As the crisis has worsened, many Indian Americans are struggling to cope with the trauma unfolding back home, juxtaposed with a vaccination drive that has reached nearly half of Americans and anticipation of a “return to normalcy” by July 4. Many are watching friends and loved ones pass away from afar, unable to travel to see grieving relatives, while witnessing the breakdown of India’s medical system.“I don’t know an Indian American family in this country who hasn’t been affected in terms of knowing someone who has either died or been very, very sick,” Rep. Ro Khanna, the congressman for California’s 17th district, said in a phone interview this week. “The scale of this is unimaginable.
The country appears to be breaking a tough third wave of the virus, and one of its tools is the AstraZeneca vaccine, which it spent months questioning.
A combination of AstraZeneca Plc's (NASDAQ: AZN ) Imfinzi (durvalumab), tremelimumab, and chemotherapy has extended overall survival (OS) when used as a first-line treatment for stage IV (metastatic) non-small cell lung cancer (NSCLC). A final analysis … Full story available on Benzinga.com
Booster shots of COVID-19 vaccine probably won't cause worse side effects than the original vaccines, experts predict↳ 15:15, Business Insider • Développer
Summary List Placement COVID-19 vaccine booster shots probably won't cause worse side effects than the original vaccines, two leading experts have told Insider — although others say it's too early to say. A booster shot is an additional dose of a vaccine that augments the body's immune response. The tetanus vaccine requires an additional dose 10 years later to maintain immunity, for example. A booster for COVID-19 would either be a third dose of the same two-dose vaccine, or a bespoke dose designed for variants. Moderna, Pfizer , and AstraZeneca are all testing both options with trial results expected later this year, including to see whether an additional dose helps protect against coronavirus variants, particularly the worrisome variant from South Africa, called B.1.351, that can sometimes escape the immune response. The original two-dose COVID-19 vaccines made by the three drugmakers usually cause side effects that self-resolve after a few days. "It will be no different or worse than the second dose," Amesh Adalja, assistant professor at the Johns Hopkins University Center for Health Security told Insider.
Fifty lakh doses of ‘Covishield' vaccine earmarked by the Serum Institute for export to the United Kingdom have now been made available for the inoculation of 18-44 age group in 21 states/UTs in India, amid a surge in COVID-19 cases, official sources said.The Centre's decision to allocate these doses to 21 states and Union territories (UTs) came after Prakash Kumar Singh, director, Government and Regulatory Affairs at Pune-based Serum Institute of India, recently wrote to the Union health ministry seeking permission for the same.The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of Covishield to the UK, citing an agreement with AstraZeneca in this regard, while assuring India that its own anti-coronavirus vaccination programme will not be disturbed due to this supply."The stock of 50 lakh doses of Covishield vaccine is now available for inoculation of 18-44 age group people in 21 states and UTs," an official source said.The ministry has asked the states to contact the company and initiate procurement activity promptly.
People under 40 will be offered an alternative to the Oxford/AstraZeneca vaccine where possible and while infection rates remain low, following a recommendation from government advisers. The Joint Committee on Vaccination and Immunisation (JCVI) reviewed the speed and uptake of Covid vaccines in the UK and the latest figures on very rare blood clots after first shots of the AstraZeneca vaccine Covid: people under 40 in UK to get alternative to AstraZeneca jab Coronavirus – latest updates Continue reading…
Friday: national cabinet will discuss repatriation plans today. Plus: NSW government refers environmental offset purchases to watchdog Good morning – did you stay up to watch the meteors ? It’s Friday 7 May, and this is Imogen Dewey with the latest news on Covid restrictions and the lead-up to the budget , plus warnings over Queensland’s proposed coercive control laws . The Morrison government is expected to begin repatriating Australians stranded (an estimated 9,000) amid India’s deadly second Covid wave as soon as its travel ban ends on 15 May , with evacuated citizens and permanent residents to quarantine at Howard Springs near Darwin. Scott Morrison is expected to announce details today. New South Wales yesterday announced new restrictions for greater Sydney , including Wollongong, the Central Coast and the Blue Mountains, following two cases of local Covid transmission in Sydney’s east. New Zealand has temporarily suspended quarantine-free travel from the state – initially for 48 hours – while the source of the infections is investigated.
- ← précédent
- suivant →